Anebulo Pharmaceuticals, Inc. (ANEB)

$4.15

-0.09 (-2.12%)
Rating:
Recommendation:
-
Symbol ANEB
Price $4.15
Beta 0.000
Volume Avg. 0.02M
Market Cap 96.880M
Shares () -
52 Week Range 2.67-7.885
1y Target Est -
DCF Unlevered ANEB DCF ->
DCF Levered ANEB LDCF ->
ROE -173.76% Strong Sell
ROA -194.88% Strong Sell
Operating Margin -
Debt / Equity 0.50% Neutral
P/E -
P/B 5.64 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest ANEB news


Healthcare
Biotechnology
NASDAQ Capital Market

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The company was incorporated in 2020 and is based in Lakeway, Texas.